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Summary.-Continuous administration of 0.040/0 N-n-propyl-N-formylhydrazine
(PFH) for life in drinking water to 6-week-old randomly bred Swiss mice induced
tumours of the lungs, preputial glands, liver and gall bladder. The tumour incidences
in these 4 tissues were 91, 22, 8 and 6%, whereas in the untreated controls they were
25,0,0-5 and 0.50", respectively. The higher dose of0.080/( PFH, given under identical
conditions, induced only tumours of the lungs, liver and gall bladder in lower inci-
dences, since the compound was too toxic for the mice. Histopathologically, the
tumours were classified as adenomas and adenocarcinomas of the lungs, squamous-
cell papillomas, and carcinomas and fibrosarcoma of preputial glands, benign hepa-
tomas and liver-cell carcinoma, as well as adenomas and adenocarcinoma of the gall
bladder.
The investigation is part of our structure/activity relationship inquiry aimed at
revealing the mechanism of action of the N-alkyl-N-formylhydrazine series of
chemicals.
THE PRESENT careinogenesis study witli
N-n-propyl-N-formylhydrazine (PFH) in
mice is a continuation of a structure/
activity inqtiir3, conducted with substitti-
ted hydrazines. Earlierinvestigations were
performed in this species with structural
homologues of PFH, including N-methyl-
N-formylhydrazine (MFR), N-ethyl-N-
formylhydrazine and N-n-butyl-N-formyl-
hydrazine (Totli & Nagel, 1978; Toth
et al., 1979 Toth & Nagel, 1908a, b). At
the beginning, we selected MFH as the
first step in otir inquiry because this
chemical is an ingredient of the edible
false morel mushroom Gyroinitra e8culenta
(List & Luft, 1968; Schmidliii-Me'sza'ros,
1-975; Pyysalo & Niskaneii, 1977). It is
known that the human poptilation is
exposed to some extent, in certain areas,
to this hazardous chemical (Miller, 1972).
Subseqttently, other N-alkyl-N-formyl-
hydrazines were investigated to determine
the possible relationship between chemi-
cal structure aiid tumour development at,
specific, organ sites.
The current study proves the carcino-
genicity of PFH given to Swiss mice at
inaximum tolerated dose levels in drinking
water for life.
AIATERIALS AND METHODS
Swiss albino mice from thecolonyrandomly
bred by us since 1951 -%.,ere used. They were
housed inplastic cages NA-ith granular cellulose
bedding, separated according to sex in groups
of .5, and given Illayne-Lab blox diet in regu-
lar pellets (Allied Mills, Inc., Chicago,
Illinois) and tap A.,ater or the chemical solu-
tion ad libitmn.
The chemical used was N-n-propyl-N-
formylhydrazine (PFH; Figure); mol. wt,
102-14; b.p., 98-100'C at 12 mm; purit.T
> 97%. PFH NNas synthesized in this, labora-
tory in the folloNNIng -%N-ay (Kost & kSagitullin,
1963):
n-Propylhydi-azine.-To avigorously stirred
solution of 1-0 kg (26-5 mol) of hydrazine
i-iionohydrate NN-as added dropNN-ise 285 g (2-3
inol) ofn-propyl bromide. During the addition
and 3 Ii after, the temperature -%.,as main-
tained at 45'C. The reaction mixture -%Aas con-No. ofsurvivors (age inweeks)
K-
t I
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TABLEI.-Treatment and8urvival rate in N-n-propyl-N-,formylhydrazine (PFH)-treated
and controlSWi8S MiCe
PHF in
drinking Initial No.
water andsex
Group for life ofmice
1 0-08% 50y
50d
2 0-04% 50y
50d
3 Nil 100y
lood
.10 20 30
50 49 40
50 37 11
50 50 50
50 48 45
100 99 98
100 100 100
40
23
2
50
32
92
96
50 60 70 80 90 100 110
19 13 3
45 35 18 2
23 5
83 77 70 55 45 30 16
91 81 63 44 28 11 4
120 130 140 150
6 1
1
1
that the treatments at both dose levels
significantly shortened the survival time.
The number and percentages of animals
with tumours and their ages at death
(latent periods) are summarized in Table
11. The 4statisticallysignificantneoplasms
were found in lungs, preputial glands,
liver, and gall bladder, and are described
in detail below:
Lung tumours
Of the females treated with the high
dose, 22 (44%) developed 252 tumours in
these organs. Of these, 19 mice had 188
adenomas and 3 mice had 50 adenomas
and 14 adenocareinomas. In the males
treated with the high dose, 7 (14%) de-
veloped 54 adenomas.
Ofthefemales treatedwith the lowdose,
49 (98%) developed 751 tumours of the
lungs. Ofthese, 18 mice had 177 adenomas
and 31 mice developed 461 adenomas and
113 adenocareinomas. In the males treated
with the low dose, 42 (84%) developed
546 tumours in the lungs. Of these, 26
mice had 191 adenomas and 16 mice had
300 adenomas and 55 adenocarcinomas.
Macroscopically andhistologically these
lesions were similar to those described in
this laboratory in this mouse strain (Toth
& Shimizu, 1974; Toth et al., 1979).
Preputial-gland tumours
Ofthe males treated with thehigh dose,
1 (2%) developed a squamous-cell car-
cinoma in this organ.
Of the males treated with the low dose,
11 (22%) developed tumours in thisgland.
Of these, 2 were classified as squamous-
cell papillomas, 8 as squamous-cell car-
cinomas and the remaining one as a
squamous-cell carcinoma jointly with a
fibrosarcoma.
Grossly and histologically the above
lesions were similar to those described
earlier by other investigators (Hiraga &
Fujii, 1977).
Liver tumours
Of the females treated with the high
dose, 5 (10%) developed tumours in this
organ. Ofthese, 4 were classified asbenign hepatomas and the remaining one as a
liver-cell carcinoma.
Of the mice treated with the low dose,
6 females (12%) and 2 males (4%) de-
veloped benign hepatomas.
Grossly and histopathologically the in-
duced tumours were similar to those
described earlier by us (Toth et al., 1964).
Gall-bladder tumours
Of the females treated with the high
dose, 5 (10%) developed tumours in this
organ. Ofthese, 4 were classified as adeno-
mas and the remaining one as an adeno-
carcinoma. In the males treated with the
high dose, 2 (4%) developed adenomas of
the gall bladder.
Of the mice treated with the low dose,
5 females (10%) and I male (2%) de-
veloped benign adenomas of this organ.
Macroscopically andhistologically these
tumours were similar to those published
previously by us in other experiments
(Toth & Nagel, 1978; Toth et al., 1979).925 N-n-PROPYL-N-FORMYLHYDRAZINE TUMORIGENESIS
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Other tumours
In a number of instances other types of
neoplasms were also observed, and are
listed in Table II. Since they occurred in
low incidences, their appearances cannot
be attributed to the treatment.
DISCUSSION
The present investigation shows that
lifetime administration of 0 040o PFH in
drinking water to randomly bred 6-week-
old Swiss mice induced tumours of the
lungs, preputial glands, liver and gall
bladder. In females, the tumour incidences
in these 4 tissues were 98 (P < 0 00001), 0,
12 (P < 0*03) and 10% (P < 0 01 1), respec-
tively; in males they were 84 (P < 0 00001),
22 (P < 0.0001), 4, and 2% respectively.
At the 0 08% dose level these tumour
incidences in females were 44 (P < 0 04),
0, 10 (P<0 008) and 10% (P<0*015),
while in males they were 14, 2, 0 and 40o
respectively. In untreated controls, the
corresponding tumour incidence was 25, 0,
1, and 1%/ in females and 26, 0, 0, and 000
in males. Statistical analysis was carried
out by Fisher's exact probability test for
2 x 2 tables and by Peto's method (Armi-
tage, 1971; Peto, 1974). Histopathologic-
ally, the tumours were classified as adeno-
mas and adenocarcinomas of lungs, squa-
mous-cell papillomas and carcinomas and
fibrosarcoma of preputial glands, benign
hepatomas and liver-cell carcinoma and
adenomas, and adenocarcinoma of gall
bladder.
Past studies have concerned the effect of
chemical structureon tumour development
As a first move, MFH, given at the maxi-
mum tolerated dose of 0-0039% to Swiss
mice, induced tumours of lungs (770%),
liver (46%)0 blood vessels (21%), bile ducts
(70%) and gall bladder (10%) (Toth &
Nagel, 1978; Toth et al., 1979). Subse-
quently, N-ethyl-N-formylhydrazine ad-
ministered at a 0.02% dose under condi-
tions similar to those of MFH, produced
tumours of the lungs (88%) blood vessels
(790o), liver (13%), gall bladder (50o) and
preputial glands (100%) (Toth & Nagel,
1980a). Furthermore, as a third step,
N-n-butyl-N-formylhydrazine at a chronic
dose of 004%o, again given under condi-
tions identical to those of the previous two
compounds, elicited tumours of the lungs
(87%), preputial (66%) and clitoral glands
(10%) (Toth & Nagel, 1980b). Finally, the
presently studied PFH at a dose of 0.04%
gave rise to tumours of the lungs (91%),
preputial glands (22%), liver (6%), and
gall bladder (8%). In our untreated Swiss
mice the tumours of lungs and blood
vessels occurin moderate incidences, whilst
tumours of liver and bile ducts are rarely
seen. So far, tumours of gall bladder,
preputial and clitoral glands have not been
seen (Toth et al., 1964; Toth & Shimizu,
1974, Toth & Nagel, 1978). From these
findings it appears obvious that the leng-
thening of the N-alkyl chain influences, to
a certain extent, the target tissues from
which tumours emerge. The precise nature
of the mode of action of these chemicals
remains to be elucidated.
To date, 48 hydrazines, hydrazides and
hydrazones were shown to be carcinogenic
in experimental animals. These chemicals
are indeed powerful carcinogens, since they
induced tumours in over two dozen tissues
and organs of mice, hamsters and rats
(Juih'asz et al., 1957; Biancifiori & Ribacchi,
1962; Morris et al., 1969; Druckrey, 1970;
Toth, 1975, 1980). It is of interest to note
here that the human population is exposed
to about one half of these compounds in
the form of drugs, agricultural herbicides
or industrial chemicals, and as naturally
occurring substances such as ingredients
of edible mushrooms and tobacco (Leven-
berg, 1960; List & Luft, 1968; Merck
Index, 1976; Schmeltz et al., 1977; LaRue,
1977).
Thtis stuidy wvas stipporte(l by U.S. P.H.S. Contract
NOI-CP-05629 from the National Cancer Institute.
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